MPM Capital is an investment firm that invests in early-stage companies developing innovative therapeutic technologies in oncology.
MPM Capital is a healthcare investment firm that invests in early-stage companies developing innovative therapeutic technologies in oncology. The firm is founding and investing in life sciences companies both public and private that seek to cure major diseases by translating scientific innovations into positive clinical outcomes.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |
Oct 19, 2021
Protego Biopharma
|
Series A | $51.04M | Biopharma | Yes |
Mar 31, 2021
Entrada Therapeutics
|
Series B | $116M | Biotechnology | — |
Mar 26, 2020
ReCode Therapeutics
|
Series A | $80M | Biopharma | — |
Dec 18, 2018
Entrada Therapeutics
|
Series A | $59M | Biotechnology | Yes |